Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Overexpression of TEL-MN1 Fusion Enhances Resistance of HL-60 Cells to Idarubicin.

Gong S, Guo M, Tang G, Yang J, Qiu H.

Chemotherapy. 2019 Mar 6;63(6):308-314. doi: 10.1159/000495073. [Epub ahead of print]

PMID:
30840968
2.
4.

Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.

Gotou M, Hanamura I, Nagoshi H, Wakabayashi M, Sakamoto N, Tsunekawa N, Horio T, Goto M, Mizuno S, Takahashi M, Suganuma K, Yamamoto H, Hiramatsu A, Watarai M, Shikami M, Imamura A, Mihara H, Taki T, Miwa H, Taniwaki M, Nitta M.

Genes Chromosomes Cancer. 2012 Jan;51(1):42-53. doi: 10.1002/gcc.20929. Epub 2011 Oct 2.

PMID:
21965128
5.

The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.

Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, Potter MD, Adams C, van Baal S, Zwarthoff EC, Roussel MF, Grosveld GC.

Mol Cell Biol. 2000 Dec;20(24):9281-93.

6.

MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.

Carella C, Bonten J, Rehg J, Grosveld GC.

Leukemia. 2006 Sep;20(9):1582-92. Epub 2006 Jun 29.

PMID:
16810199
7.

Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.

Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, et al.

Oncogene. 1995 Apr 20;10(8):1511-9. Erratum in: Oncogene 1995 Aug 17;11(4):809.

PMID:
7731705
8.

The leukemia-associated fusion protein MN1-TEL blocks TEL-specific recognition sequences.

ter Haar WM, Meester-Smoor MA, van Wely KH, Schot CC, Janssen MJ, Geverts B, Bonten J, Grosveld GC, Houtsmuller AB, Zwarthoff EC.

PLoS One. 2012;7(9):e46085. doi: 10.1371/journal.pone.0046085. Epub 2012 Sep 26.

9.

The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription.

van Wely KH, Meester-Smoor MA, Janssen MJ, Aarnoudse AJ, Grosveld GC, Zwarthoff EC.

Oncogene. 2007 Aug 23;26(39):5733-40. Epub 2007 Mar 19.

PMID:
17369854
10.

TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin.

Majsterek I, Slupianek A, Blasiak J.

Anticancer Drugs. 2003 Sep;14(8):625-31.

PMID:
14501384
11.

TEL/JAK2 tyrosine kinase inhibits DNA repair in the presence of amifostine.

Gloc E, Warszawski M, Młynarski W, Stolarska M, Hoser G, Skorski T, Błasiak J.

Acta Biochim Pol. 2002;49(1):121-8.

12.

Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases.

Shao H, Cen J, Chen S, Qiu H, Pan J.

Ann Hematol. 2018 Mar;97(3):417-424. doi: 10.1007/s00277-017-3208-2. Epub 2017 Dec 22. Review.

PMID:
29273914
13.

Analysis of TEL proteins in human leukemias.

Poirel H, Lacronique V, Mauchauffé M, Le Coniat M, Raffoux E, Daniel MT, Erickson P, Drabkin H, MacLeod RA, Drexler HG, Ghysdael J, Berger R, Bernard OA.

Oncogene. 1998 Jun 4;16(22):2895-903.

14.

[Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12)].

Shao H, Yang Q, Gong Y, Bai S, Zhang J, Wang Y, Shen J, Wu C, Qiu H, Chen S, Pan J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Feb 10;36(2):112-115. doi: 10.3760/cma.j.issn.1003-9406.2019.02.004. Chinese.

PMID:
30703225
15.

[Advance of study on MN1 gene in acute myeloid leukemia - review].

Sun HM, Qian SX, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):504-8. Review. Chinese.

PMID:
19379599
16.

MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.

Heuser M, Argiropoulos B, Kuchenbauer F, Yung E, Piper J, Fung S, Schlenk RF, Dohner K, Hinrichsen T, Rudolph C, Schambach A, Baum C, Schlegelberger B, Dohner H, Ganser A, Humphries RK.

Blood. 2007 Sep 1;110(5):1639-47. Epub 2007 May 9.

17.

High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.

Heuser M, Beutel G, Krauter J, Döhner K, von Neuhoff N, Schlegelberger B, Ganser A.

Blood. 2006 Dec 1;108(12):3898-905. Epub 2006 Aug 15.

18.

MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression.

Meester-Smoor MA, Janssen MJ, Grosveld GC, de Klein A, van IJcken WF, Douben H, Zwarthoff EC.

Carcinogenesis. 2008 Oct;29(10):2025-34. doi: 10.1093/carcin/bgn168. Epub 2008 Jul 16.

19.

Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells.

Błasiak J, Gloc E, Młynarski W, Drzewoski J, Skórski T.

Leuk Res. 2002 Dec;26(12):1093-6.

PMID:
12443881
20.

MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.

Larmonie NSD, Arentsen-Peters TCJM, Obulkasim A, Valerio D, Sonneveld E, Danen-van Oorschot AA, de Haas V, Reinhardt D, Zimmermann M, Trka J, Baruchel A, Pieters R, van den Heuvel-Eibrink MM, Zwaan CM, Fornerod M.

Oncogene. 2018 Jan 4;37(1):107-115. doi: 10.1038/onc.2017.293. Epub 2017 Sep 11.

PMID:
28892045

Supplemental Content

Support Center